According to the report analysis, ‘Global qPCR and dPCR Market Forecast up to 2025’
states that the global qPCR and dPCR market will grow at a CAGR of 9.2% during
the forecast period. Whereas, the market has perceived sturdy growth in the
past few years and enhancement in the technology with the introduction of
highly sensitive, strong and consistent systems in the market. The market is propelled
by increasing the ultimatum for the qPCR and dPCR in genetic and molecular
testing, rising the private investment and funds, and augmenting the
requirement for the biomarker-based tests.
Nonetheless, the report also suggests that there are
several key players which are functioning in this market more actively for
attaining the high of market share and leading the speedy growth across the
globe while developing the working strategies and increasing the investment
amount in the several research and development programs includes Thermo Fisher
Scientific, Bio-Rad Laboratories, Danaher Corp., Agilent Technologies, Inc., Qiagen
N.V., Hoffmann-La Roche, Abbott Laboratories, Promega Corp., Eppendorf AG, BioMerieux
S.A., Merck KGaA and several others.
Furthermore, the market endures to produce and is one
of the most extensively utilized the technology for the quantification of
nucleic acid. The advanced technology has created the device simple, fast, and truthful.
Vendors are effectively aiming towards the new product launches and directing
towards end-user's perspective.
Based on the region, the North America region dominated
for the principal share of the global qPCR and dPCR market in 2018. The augmented
utilization of PCR in proteomics & genomics, advanced technologies such as
qPCR and PCR-based laboratory enhanced the tests for rare genetic diseases,
cancers, and infectious diseases are fueling the market in North America. The
Asia Pacific region is predicted to observe the wildest growth rate owing to the
large patient pool and increasing the healthcare expenditure.
However, the sector of product type involves the
instruments, reagents and consumables and software and services. Whereas, the
reagents and consumables segment engaged the largest share in 2018 owing to its
unconventional features and specialty-based operations. Many companies are extremely
focusing on delivering even software services. In March 2017, ThermoFisher
Scientific attained the Core Informatics, a supplier of the cloud-based
platform supporting scientific data management.
Not only has this, based on the applications the
market of Qpcr and Dpcr is divided into clinical diagnostics, biomedical
research and several others. For instance, the biomedical research registered the
maximum share in 2018 followed by the clinical diagnostics. The efficacious
completion of Human genome project has fueled the growth of qPCR and dPCR
market.
Furthermore, Merger and acquisition have been foremost
strategy followed by the key players in the market to continue their leadership
in the market. The Thermo Fisher Scientific deployed around USD 5.5 billion on
acquisitions in 2016. This is anticipated to augment the offerings and strategic
positioning of the company. Yet, it is anticipated that the market of QPCR and
DPCR will increase across the globe more positively over the recent decades.
For more information on the research
report, refer to below link:-
Related Report:-
Contact Us:-
Ken Research
Ankur Gupta, Head Marketing & Communications
Sales@kenresearch.com
+91-9015378249
Ken Research
Ankur Gupta, Head Marketing & Communications
Sales@kenresearch.com
+91-9015378249
